AlzeCure Pharma
4.11.2021 10:21:53 CET | ACCESS Newswire | Press release
STOCKHOLM, SE / ACCESSWIRE / November 04, 2021 / AlzeCure Pharma (STO:ALZCUR) (FRA:AC6)
AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a pharmaceutical company that develops a broad portfolio of drug candidates for diseases affecting the central nervous system, with projects in both Alzheimer's disease and pain, today announced that the company is participating at Redeye Life Science Day 2021 on November 11 at 14:30 CEST, where CEO Martin Jönsson will present the company's latest developments. The presentation will be followed by a Q&A with external experts on-site and Redeye's analysts.
The presentation will be held in English and live streamed via https://www.redeye.se/events/815899/redeye-life-science-day-2021 . The recorded presentation and the slide set will also be available afterwards on AlzeCure's website https://www.alzecurepharma.se/en/presentations-and-interviews/ .
For more information, please contact
Martin Jönsson, CEO
Tel: +46 707 86 94 43
martin.jonsson@alzecurepharma.com
About AlzeCure Pharma AB (publ)
AlzeCure® is a Swedish pharmaceutical company that develops new innovative drug therapies for the treatment of severe diseases and conditions that affect the central nervous system, such as Alzheimer's disease and pain - indications for which currently available treatment is very limited. The company is listed on Nasdaq First North Premier Growth Market and is developing several parallel drug candidates based on three research platforms: NeuroRestore®, Alzstatin® and Painless.
NeuroRestore consists of two symptomatic drug candidates where the unique mechanism of action allows for multiple indications, including Alzheimer's disease, as well as cognitive disorders associated with traumatic brain injury, sleep apnea and Parkinson's disease. The Alzstatin platform focuses on developing disease-modifying and preventive drug candidates for early treatment of Alzheimer's disease and comprises two drug candidates. Painless is the company's research platform in the field of pain and contains two projects: ACD440, which is a drug candidate in the clinical development phase for the treatment of neuropathic pain, and TrkA-NAM, which targets severe pain in conditions such as osteoarthritis. AlzeCure aims to pursue its own projects through preclinical research and development to an early clinical phase, and is continually working on business development to find suitable outlicensing solutions with other pharmaceutical companies.
FNCA Sweden AB, +46(0)8 528 00 399 info@fnca.se , is the company's Certified Adviser. For more information, please visit www.alzecurepharma.se .
Image Attachments
Martin Jönsson CEO AlzeCure Pharma
Attachments
AlzeCure presents at Redeye Life Science Day 2021 on November 11
SOURCE: AlzeCure Pharma
View source version on accesswire.com:
https://www.accesswire.com/671149/AlzeCure-Presents-at-Redeye-Life-Science-Day-2021-on-November-11
To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
About ACCESS Newswire
Subscribe to releases from ACCESS Newswire
Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from ACCESS Newswire
Polaris Renewable Energy Announces Q4 and Annual 2025 Results19.2.2026 13:50:00 CET | Press release
TORONTO, ONTARIO / ACCESS Newswire / February 19, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the year ended December 31, 2025. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise. HIGHLIGHTS For the quarter ended December 31, 2025 consolidated energy production increased by 1% when compared to the same quarter in 2024, while annual consolidated energy production was 810,731 MWh for the year ended December 31, 2025 versus 764,756 for the year ended December 31, 2024. The Company generated $80.5 million in revenue for the year ended December 31, 2025, compared to $75.8 million in the same pe
Honoring Nelson Mandela's Legacy of Financial Empowerment and Inclusion19.2.2026 13:47:00 CET | Press release
Datavault AI and Nelson Mandela Family Members, Re Mandela Dlamini & Manaway L.L.C., Announce Formation of Mandela Digital Ventures to Develop Digital Asset Products Aligned with the Legacy of Nelson Mandela PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 19, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, and Mandela Dlamini & Manaway L.L.C., a Wyoming based organization dedicated to perpetuating Nelson Mandela's vision of equality and human dignity, today announced a strategic joint venture, Mandela Digital Ventures to develop and launch a new suite of digital asset products. The collaboration will create blockchain-based financial tools and assets, designed to drive financial inclusion for underserved populations worldwide. These products will directly reflect the enduring values of Nelson Mandela: freedom, justice, reconciliation,
From Seoul's Global K-Wave to Web3 Leadership: Datavault AI and TBURN Chain Align K-Pop, Esports, and Korean Cultural Exports with Enterprise-Grade Data Asset Infrastructure and Tokenized Real World Assets18.2.2026 13:00:00 CET | Press release
PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire / February 18, 2026 / Datavault AI Inc. (NASDAQ:DVLT) ("Datavault AI" or the "Company"), a leader in data monetization, credentialing, digital engagement and real-world asset (RWA) tokenization technologies, today announced the execution of a collaboration agreement with TBURN Chain Foundation ("TBURN"), a high-performance blockchain infrastructure platform. The agreement establishes a strategic framework to explore integration of Datavault's data asset tokenization, valuation, and Information Data Exchange® (IDE) technologies with TBURN's high-throughput blockchain network, which is designed to support enterprise-scale transaction processing and near-instant settlement. TBURN is engaged across global esports and entertainment ecosystems, including partnerships involving esports champion Faker and K-Pop acts such as BLACKPINK, providing potential pathways for authenticated digital engagement and data-driven monetization models. Originating f
The Numbers are Clear: Latest Iteration of Stagwell's News Advertising Study Shows Germans Love Their News18.2.2026 11:00:00 CET | Press release
Stagwell, Axel Springer, Teads and The Trade Desk partner on German News Advertising Study, drawing insights from over 11,000 respondents Study finds the proportion of ‘news junkies' in Germany is highest of all the surveyed markets BERLIN, GERMANY / ACCESS Newswire / February 18, 2026 / Stagwell, the global challenger network transforming marketing through AI, released the latest installment of its News Advertising Study in partnership with Axel Springer, Teads and The Trade Desk. The survey, fielded among 11,282 adults in Germany, builds on Stagwell's prior News Advertising studies conducted in Asia Pacific, Canada, the U.S. and UK. This regional study further reinforces it is safe for brands to advertise adjacent to quality news content agnostic of the topic. "The Future of News research for the German market illustrates how important it is for brands to advertise in quality news publications. Germany has a 10-percentage point higher share of news enthusiasts than other markets, and
Kraft Heinz, Braskem, and Tenaris to headline OMP Conference São Paulo 202617.2.2026 15:00:00 CET | Press release
Global industry leaders showcase real-world results and AI-driven supply chain planning innovations SÃO PAULO, BR / ACCESS Newswire / February 17, 2026 / OMP, a leading provider of AI-powered supply chain planning solutions, brings its REAL conference series to Latin America with a one-day event in São Paulo on April 16, 2026. The conference will bring together Fortune 500 leaders to share how they are transforming global operations through digital innovation. Under the theme "Real expertise. Real solutions. Real results," the conference focuses on the practical application of AI in complex supply chain environments. The agenda is anchored by three global powerhouses who will provide a "behind-the-scenes" look at their digital transformation journeys in partnership with OMP's Unison Planning™: Kraft Heinz, a global food and beverage company, will demonstrate how data-driven planning, AI-enabled optimization, and end-to-end visibility are building a more agile and sustainable value chai
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom